High Court Overturns Landmark Generic-Drug Liability Ruling
The U.S. Supreme Court on Monday reversed the First Circuit's holding that the user of a generic drug can bring a state-law design defect claim against its manufacturer, pointing out that...To view the full article, register now.
Already a subscriber? Click here to view full article